What are the treatment options for insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Insomnia

Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the first-line treatment for all adults with chronic insomnia disorder due to its proven effectiveness and lack of side effects. 1

First-Line Treatment: Psychological and Behavioral Interventions

Cognitive Behavioral Therapy for Insomnia (CBT-I)

  • CBT-I is strongly recommended as the initial treatment for chronic insomnia based on moderate-quality evidence 1
  • CBT-I is effective for both primary and comorbid (secondary) insomnia 1
  • CBT-I typically includes multiple components: cognitive therapy, stimulus control, sleep restriction, with or without relaxation therapy 1
  • CBT-I is effective for adults of all ages, including older adults and chronic hypnotic users 1, 2
  • CBT-I produces results equivalent to sleep medication but with no side effects, fewer relapses, and continued improvement after treatment ends 3

Other Effective Behavioral Interventions

  • Stimulus control therapy (establishing a positive association between bed and sleep) is an effective individual therapy 1, 2
  • Relaxation therapy is effective as a standalone treatment for chronic insomnia 1, 2
  • Sleep restriction therapy is recommended for chronic insomnia 1
  • Brief Behavioral Interventions (BBIs) are potentially useful with minimal undesirable effects 1
  • Multicomponent therapy (without cognitive therapy) is effective and recommended 1

Sleep Hygiene Considerations

  • Sleep hygiene alone is insufficient for treating chronic insomnia 1, 4
  • Sleep hygiene should be used in combination with other therapies, not as a standalone treatment 1, 4
  • All patients with chronic insomnia should adhere to rules of good sleep hygiene as part of a comprehensive treatment plan 1

Second-Line Treatment: Pharmacological Options

When CBT-I alone is unsuccessful, pharmacological therapy may be considered using a shared decision-making approach that discusses benefits, harms, and costs of short-term medication use 1.

Recommended Medication Sequence

  1. Short-intermediate acting benzodiazepine receptor agonists or ramelteon 1

    • Non-benzodiazepines (zolpidem, eszopiclone, zaleplon) 1, 5
    • Benzodiazepines (temazepam) 1
    • Ramelteon for insomnia characterized by difficulty with sleep onset 6
  2. If initial agent unsuccessful, try alternate short-intermediate acting BzRAs or ramelteon 1

  3. Sedating antidepressants (especially with comorbid depression/anxiety) 1

    • Options include trazodone, amitriptyline, doxepin, and mirtazapine 1
  4. Combined BzRA or ramelteon with sedating antidepressant 1

  5. Other sedating agents 1

    • Anti-epilepsy medications (gabapentin, tiagabine) 1
    • Atypical antipsychotics (quetiapine, olanzapine) - only suitable for patients with comorbid conditions who may benefit from primary action of these drugs 1

Important Medication Considerations

  • Short-term hypnotic treatment should be supplemented with behavioral and cognitive therapies when possible 1
  • Over-the-counter antihistamines and herbal/nutritional substances (valerian, melatonin) are not recommended due to lack of efficacy and safety data 1
  • Barbiturates, barbiturate-type drugs, and chloral hydrate are not recommended 1
  • Zolpidem is FDA-approved for short-term treatment of insomnia characterized by difficulties with sleep initiation 5
  • Newer-generation nonbenzodiazepines have better safety profiles than traditional benzodiazepines for long-term treatment 7

Treatment Selection Factors

When selecting pharmacological treatment, consider: 1

  • Symptom pattern (sleep onset vs. maintenance issues)
  • Treatment goals
  • Past treatment responses
  • Patient preference
  • Cost
  • Availability of other treatments
  • Comorbid conditions
  • Contraindications
  • Medication interactions
  • Side effects

Monitoring and Follow-up

  • Sleep diary data should be collected before and during treatment, and in case of relapse 1
  • Clinical reassessment should occur every few weeks until insomnia stabilizes or resolves 1
  • After stabilization, follow-up every 6 months is recommended as relapse rates for insomnia are high 1
  • When a single treatment is ineffective, consider other behavioral therapies, pharmacological options, combined therapies, or reevaluation for comorbid disorders 1

Common Pitfalls to Avoid

  • Relying solely on sleep hygiene education without additional interventions 1
  • Using over-the-counter antihistamines or alcohol as sleep aids 1, 7
  • Prescribing medications without addressing behavioral components 1
  • Failing to reassess treatment effectiveness regularly 1
  • Not considering potential for dependence with long-term benzodiazepine use 7
  • Overlooking comorbid conditions that may be contributing to insomnia 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.